Abstract
COPD is a condition characterized by progressive airflow obstruction which is rather insensible to bronchodilators. The pathogenetic mechanisms of this disorder are multifaceted, encompassing pulmonary inflammation, small airway remodelling, emphysema and mucous hypersecretion. As our comprehension of the heterogeneous pathology of the disease has improved it has been recognized that the ongoing inflammatory process in COPD is correlated with the relentlessness of this condition. Therefore, the scientific interest has been directed in the development of new anti-inflammatory drugs targeting pulmonary inflammation. In this survey, we will try to evaluate current treatment options and the potential and efficacy of new treatment modalities.
Current Respiratory Medicine Reviews
Title: COPD: Optimal Current Treatment Strategies and Promising New Therapeutic Modalities
Volume: 5 Issue: 2
Author(s): Ioannis Starakis
Affiliation:
Abstract: COPD is a condition characterized by progressive airflow obstruction which is rather insensible to bronchodilators. The pathogenetic mechanisms of this disorder are multifaceted, encompassing pulmonary inflammation, small airway remodelling, emphysema and mucous hypersecretion. As our comprehension of the heterogeneous pathology of the disease has improved it has been recognized that the ongoing inflammatory process in COPD is correlated with the relentlessness of this condition. Therefore, the scientific interest has been directed in the development of new anti-inflammatory drugs targeting pulmonary inflammation. In this survey, we will try to evaluate current treatment options and the potential and efficacy of new treatment modalities.
Export Options
About this article
Cite this article as:
Starakis Ioannis, COPD: Optimal Current Treatment Strategies and Promising New Therapeutic Modalities, Current Respiratory Medicine Reviews 2009; 5 (2) . https://dx.doi.org/10.2174/157339809788189923
DOI https://dx.doi.org/10.2174/157339809788189923 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Therapeutical Potential of CB<sub>2</sub> Receptors in Immune-Related Diseases
Current Molecular Pharmacology Inhibition of Mitochondrial Membrane Permeability as a Putative Pharmacological Target for Cardioprotection
Current Medicinal Chemistry Human Amnion–Derived Cells as a Reliable Source of Stem Cells
Current Molecular Medicine Levosimendan for Perioperative Cardioprotection: Myth or Reality?
Current Cardiology Reviews Potential Benefits and Limits of Psychopharmacological Therapies in Pervasive Developmental Disorders
Current Clinical Pharmacology Acute Physical Stress Increases Serum Levels of Specific microRNAs
MicroRNA Pregnane X Receptor and its Potential Role in Drug Resistance in Cancer Treatment
Recent Patents on Anti-Cancer Drug Discovery Lone Atrial Fibrillation: Electrophysiology, Risk Factors, Catheter Ablation and Other Non-pharmacologic Treatments
Current Pharmaceutical Design Serum Collagen Markers and Heart Failure
Cardiovascular & Hematological Disorders-Drug Targets Systemic Sclerosis-Related Pulmonary Hypertension: Unique Characteristics and Future Treatment Targets
Current Pharmaceutical Design Analysis of the L-Arginine / Nitric Oxide Pathway: The Unique Role of Mass Spectrometry
Current Pharmaceutical Analysis Editorial (Thematic Issue: Frontiers in Atherosclerosis, Heart Disease and Diabetes)
Cardiovascular & Hematological Disorders-Drug Targets Commentary: Participation of Sox-1 Expression and Signaling of β-Catenin in the Pathophysiology of Generalized Seizures in Cerebellum of Rat
CNS & Neurological Disorders - Drug Targets Bergamot Juice Extract Inhibits Proliferation by Inducing Apoptosis in Human Colon Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Isoindole Derivatives: Propitious Anticancer Structural Motifs
Current Topics in Medicinal Chemistry Influence of Statin Use on Endothelial Function: From Bench to Clinics
Current Pharmaceutical Design Biologic Agents for Treatment of Rheumatoid Arthritis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Nanomaterial Based Approaches for the Diagnosis and Therapy of Cardiovascular Diseases
Current Pharmaceutical Design Editorial: Recent Advances in Cardiovascular and Circulatory Signalling
Current Vascular Pharmacology Exogenous Factors from Venomous and Hematophagous Animals in Drugs and Diagnostic Developments for Cardiovascular and Neurovascular Diseases
Cardiovascular & Hematological Disorders-Drug Targets